MGX filings
Corporate insider profile
Pamela Wapnick Filing Activity
Latest reported as Chief Financial Officer of Metagenomi Therapeutics, Inc. (MGX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$3,746.32
- Latest transaction
- Jun 5, 2026
Affiliated corporations
Reported company relationships
Transaction history
